Evergreen Capital Management LLC Protalix Bio Therapeutics, Inc. Transaction History
Evergreen Capital Management LLC
- $3.91 Billion
- Q3 2025
A detailed history of Evergreen Capital Management LLC transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Evergreen Capital Management LLC holds 171,338 shares of PLX stock, worth $318,688. This represents 0.01% of its overall portfolio holdings.
Number of Shares
171,338
Previous 171,338
-0.0%
Holding current value
$318,688
Previous $253,000
50.99%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding PLX
# of Institutions
84Shares Held
10.6MCall Options Held
23.6KPut Options Held
95.4K-
Opaleye Management Inc. Boston, MA2.58MShares$4.8 Million0.96% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.32MShares$2.45 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL902KShares$1.68 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA820KShares$1.52 Million0.0% of portfolio
-
Stratos Wealth Partners, Ltd.500KShares$930,0000.01% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $92.5M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...